Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CINV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00952341
What this trial is testing

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 421
Post-approval studies (Phase 4)Study completedNCT04054193
What this trial is testing

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 103
Post-approval studies (Phase 4)UnknownNCT05434663
What this trial is testing

Safety Study of Repeat Doses of SUSTOL in Adults

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Heron Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT01442376
What this trial is testing

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Helsinn Healthcare SA 502
Post-approval studies (Phase 4)Study completedNCT04817189
What this trial is testing

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 414
Testing effectiveness (Phase 2)Ended earlyNCT00636805
What this trial is testing

Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

Who this might be right for
Brain Cancer
Duke University 63
Testing effectiveness (Phase 2)Study completedNCT01450826
What this trial is testing

Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide

Who this might be right for
NauseaVomitingGlioma
Katy Peters 136
Post-approval studies (Phase 4)Study completedNCT01659775
What this trial is testing

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
LG Life Sciences 389
Large-scale testing (Phase 3)UnknownNCT05199818
What this trial is testing

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Xiamen LP Pharmaceutical Co., Ltd 328
Testing effectiveness (Phase 2)Study completedNCT00306735
What this trial is testing

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Who this might be right for
Multiple Myeloma
Eisai Inc. 75
Early research (Phase 1)Not Yet RecruitingNCT07817004
What this trial is testing

QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Qilu Pharmaceutical (Hainan) Co., Ltd. 42
Testing effectiveness (Phase 2)Study completedNCT03948477
What this trial is testing

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

Who this might be right for
OncologyBreast CancerChemotherapy-induced Nausea and Vomiting
University of Auckland, New Zealand 160
Post-approval studies (Phase 4)Looking for participantsNCT07482891
What this trial is testing

An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Shanghai 6th People's Hospital 200
Large-scale testing (Phase 3)Study completedNCT01594749
What this trial is testing

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 1,015
Large-scale testing (Phase 3)Study completedNCT00619359
What this trial is testing

Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 2,322
Not applicableUnknownNCT00528554
What this trial is testing

Laser Acupuncture Against Nausea in Children

Who this might be right for
NauseaVomitingCancer
University Children Hospital Homburg 25
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Large-scale testing (Phase 3)Study completedNCT04437017
What this trial is testing

Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Fifth Affiliated Hospital, Sun Yat-Sen University 557
Testing effectiveness (Phase 2)UnknownNCT02205164
What this trial is testing

Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Associazione Salentina Angela Serra 134
Large-scale testing (Phase 3)Study completedNCT00337727
What this trial is testing

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Merck Sharp & Dohme LLC 848
Next Page